health biotech news today obesity drugs glp-1 New GLP-1s Are on the Way. They'll Treat a Lot More Than GLP-1 and the kidney: Medication:Tirzepatide (GLP-1 + GIP) reduce body fat

health biotech news today obesity drugs glp-1 New GLP-1s Are on the Way. They'll Treat a Lot More Than GLP-1 and the kidney: Medication:Tirzepatide (GLP-1 + GIP) reduce body fat

GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes | Nature Reviews Nephrology

Cigna subsidiary to cap employer spending on GLP-1s Executives said the move will offer plans and employers “greater predictability and control.” • less than 3 min read Cigna will cap how much employers and health plans spend on GLP-1s—diabetes drugs that have become popular weight loss options despite their hefty price tags—company executives announced Thursday

reduce body fat

Medication:Tirzepatide (GLP-1 + GIP)

To learn more, visit our Review Methodology page